Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms
The pathogenesis of aortic aneurysms involves inflammatory cell recruitment and increased levels of reactive oxygen species and matrix metalloproteases. Kimio Satoh et al . now mechanistically link the protein cyclophilin A—expressed in vascular smooth muscle cells—to these known mediators of aortic...
Saved in:
Published in | Nature Medicine Vol. 15; no. 6; pp. 649 - 656 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.06.2009
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The pathogenesis of aortic aneurysms involves inflammatory cell recruitment and increased levels of reactive oxygen species and matrix metalloproteases. Kimio Satoh
et al
. now mechanistically link the protein cyclophilin A—expressed in vascular smooth muscle cells—to these known mediators of aortic aneurysm formation and provide evidence in both mice and humans for the importance of cyclophilin A in aortic aneurysm formation.
Inflammation and oxidative stress are pathogenic mediators of many diseases, but molecules that could be therapeutic targets remain elusive. Inflammation and matrix degradation in the vasculature are crucial for abdominal aortic aneurysm (AAA) formation. Cyclophilin A (CypA, encoded by
Ppia
) is highly expressed in vascular smooth muscle cells (VSMCs), is secreted in response to reactive oxygen species (ROS) and promotes inflammation. Using the angiotensin II (AngII)-induced AAA model in
Apoe
−/−
mice, we show that
Apoe
−/−
Ppia
−/−
mice are completely protected from AngII–induced AAA formation, in contrast to
Apoe
−/−
Ppia
+/+
mice.
Apoe
−/−
Ppia
−/−
mice show decreased inflammatory cytokine expression, elastic lamina degradation and aortic expansion. These features were not altered by reconstitution of bone marrow cells from
Ppia
+/+
mice. Mechanistic studies showed that VSMC-derived intracellular and extracellular CypA are required for ROS generation and matrix metalloproteinase-2 activation. These data define a previously undescribed role for CypA in AAA formation and suggest CypA as a new target for treating cardiovascular disease. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 K.S. contributed to the design of the experiments, conducted and performed the experiments and generated the manuscript and figures. P.N. helped the design of the experiments and performed experiments. T.M., C.Y., and J.A. contributed to generating VSMC-specific CyPA transgenic mice. M.R.O. and A.M. contributed to the in vivo experiments including colony management, genotyping, and hemodynamic measurements. Z.C. and X.S. contributed to preparation of recombinant CyPA. K.A.I. contributed to the design of the experiments. B.C.B supervised the project, contributed to the design of the experiments, and wrote the manuscript. Author Contributions Present addresses: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan. |
ISSN: | 1078-8956 1546-170X |
DOI: | 10.1038/nm.1958 |